CHGCF:OTCMKTS
Chugai Pharmaceutical Co Ltd
$38.41
arrow_upward
+0.97%(+0.37) 1D
Okt 13, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa CHGCF...
Buksan
$38.41
Mataas
$38.52
Mababa
$37.23
Mkt. cap
10.36T
Avg. na dami
12.31K
Dami
13.28K
Mataas nang 52-wk
$68.08
Mababa nang 52-wk
$34.79
Beta
1.91
Mga natitirang share
1.68B
Bilang ng mga empleyado
5K
Buksan
$38.41
Mataas
$38.52
Mababa
$37.23
Mkt. cap
10.36T
Avg. na dami
12.31K
Dami
13.28K
Mataas nang 52-wk
$68.08
Mababa nang 52-wk
$34.79
Beta
1.91
Mga natitirang share
1.68B
Bilang ng mga empleyado
5K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
ad-hoc-news.de
·
13 oras ang nakalipas
Chugai reports Week 52 vamikibart data for Chugai Pharmaceutical stock
ad-hoc-news.de
·
1 araw ang nakalipas
Chugai Pharmaceutical stock after-hours at EUR 33.94
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
Tungkol sa Chugai Pharmaceutical Co Ltd